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Abstract
Protein fibrillation is believed to play an important role in the
pathology and development of several human diseases, such
as Alzheimer’s disease, Parkinson’s disease and type 2 diabetes.
Carbon dots (CDs), as a new type of nanoparticle have recently
been extensively studied for potential biological applications, but
their effects on protein fibrillation remain unexplored. In reality, any
application in biological systems will inevitably have “contact”
between proteins and CDs. In this study, human insulin was selected
as a model protein to study the effects of CDs on protein fibrillation, as
proteins may share a common mechanism to form fibrils. Hydrophobic
CDs were conjugated with dihydrolipoic acid (DHLA-CDs) to facilitate
their water solubility. Characterizations from thioflavin T fluorescence,
circular dichroism spectroscopy and atomic force microscopy
demonstrate that the presence of DHLA-CDs results in a higher rate
of human insulin fibrillation, accelerating the conformational changes
of human insulin from α-helix to β-sheet. This promoting effect is likely
associated with the locally increased concentration of human insulin
adsorbed on the surface of DHLA-CDs.

Abbreviations
AFM: Atomic Force Microscopy; CDs: Carbon Dots; DHLACDs: Dihydrolipoic Acid-conjugated Carbon Dots; QDs: Quantum
Dots; TEM: Transmission Electron Microscopy; ThT: Thioflavin T

Introduction
Formation of amyloid-like protein fibrils with cross-β-sheet
structures from protein native conformation has been indicated to
play an important role in the development of several serious human
diseases, such as Alzheimer’s disease, Parkinson’s disease, prion
diseases, and type 2 diabetes mellitus [1,2]. In spite of protein diversity
in sources, sequences and functions, protein fibrils share strikingly
similar characteristics, including nucleation-dependent kinetics,
cross-β-sheet structures, elongated morphology, and thioflavin T
(ThT) fluorescence enhancement [1,3-5]. These observations indicate
that the fibrillation of proteins may share a common molecular
mechanism. Therefore, study of the protein fibrillation process
may provide useful information and insights into the pathology,
prevention and treatment of the human diseases associated with
protein fibrillation.
With recent nanotechnological developments in nanomedicine and
biomedical engineering, much attention is focused on understanding
the interaction and toxicity of nanomaterials on cellular components,
such as proteins, plasma membranes and DNA [6-10]. Quantum dots
(QDs), a class of typical nanoparticles, have been extensively studied
with proteins to explore their potential biomedical applications. One
study illustrated that N-acetyl-L-cysteine capped CdTeQDs inhibit
amyloid beta 1-40 fibril formation in vitro [11]. On the contrary,
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other research suggested that hydrophilic coated QDs accelerate the
fibrillation of proteins (i.e., human β2-microglobulin, α-synuclein
and human serum albumin) by enhancing the formation of the critical
nucleus [12,13]. Our current knowledge of nanoparticles influencing
protein fibrillation still relies on a case-by-case approach, depending
on physical/chemical properties of proteins and nanoparticles, such
as components, charge, coating and size [12,14,15].
Another novel type of nanoparticle-carbon dots (CDs) has recently
arisen to replace QDs for biological applications. Compared with
QDs, CDs are currently attracting more and more research attention
because of their unique properties, such as excitation wavelength
dependent photoluminescence, excellent biocompatibility, low
cytotoxicity, and optical stability [16-18]. These properties make CDs
increasingly attractive for applications in biological systems. Several
studies using CDs in biological systems have shown that CDs are nontoxic and can be used for imaging in cellular environment [16,19,20].
For any application of CDs in a biological system, they are inevitably
interacting with proteins which may undergo conformational changes
to form fibrils due to the presence of CDs. However, the effect of
CDs on protein fibrillation has not been reported until most recently
(March 2015) from our group [21]. In that study, water soluble CDs
with size less than 6 nm are prepared by oxidizing carbon nano
powder and these CDs are demonstrated to inhibit human insulin
fibrillation in vitro in a concentration-dependent manner.
Insulin fibrils or plaques have been observed in vivo in
patients suffering from diabetes after insulin infusion or repeated
injection [22,23]. Insulin fibrils can be easily formed in vitro under
certain condition, such as high concentrations, low pH and high
temperatures [3,24]. In this study, human insulin was chosen to study
the effects of CDs on its fibrillation. It is worth noting that the CDs
used in this study have completely different nature from those we
reported most recently [21] in terms of size, surface properties and
components. The CDs in the present study have a hydrophobic core
capped by dihydrolipoic acid (DHLA-CDs) to increase their water
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solubility. Furthermore, the size of DHLA-CDs is much larger than
6 nm. Different concentrations of these DHLA-CDs were added to
human insulin to study the kinetics of its fibrillation. These samples
were subsequently characterized by fluorescence spectroscopy of
thioflavin T and circular dichroism spectroscopy. The morphology
of fibrils was monitored visually by atomic force microscopy (AFM).
Our investigation demonstrates that the presence of DHLA-CDs
promotes human insulin fibrillation.

Experimental Section
Materials
Recombinant human insulin, (±)-α-lipoic acid (also known as
DL-thioctic acid), 1-octadecene and thioflavin T wereobtained from
MP Biomedicals, LLC (Solon, OH). 1-Hexadecylamine, citric acid
and other chemicals were reagent grade and purchased from SigmaAldrich (St. Louis, MO). The deionized water was obtained from a
Modulab 2020 water purification system (San Antonio, TX).

Synthesis of hydrophobic carbon dots
Hydrophobic carbon dots were synthesized with the procedure
developed by Wang et al. [25]. A mixture of 15 mLof1-octadecene
and 1.5 g of1-hexadecylamine was heated in a three-neck flask under
argon flow to 300 °C, and then 1 g of citric acid was injected into the
mixture. The solution was kept at 300 °C for 3hours. After reaction,
it was cooled down in air to room temperature. The solid form of
hydrophobic carbon dots was obtained and purified by precipitating
with acetone in an ice bath. It was further characterized by UV-vis
absorption (Shimadzu UV-2600, Japan), fluorescence (Fluorolog-3,
Horiba JobinYvon, Edison, NJ), Fourier transform infrared
spectroscopy (PerkinElmer, Frontier), and atomic force microscopy
(Agilent 5420, Santa Clara, CA).

Synthesis of DHLA conjugated carbon dots (DHLA-CDs)
Dihydrolipoic acid (DHLA) was synthesized by reducing
(±)-α-lipoic acid with sodium borohydride in an ice bath and the
product was extracted by chloroform using the same procedures
developed by Clapp et al. [26]. 0.2 g of as-prepared hydrophobic
carbon dots and 1 g of DHLA were added into a12 mL mixture
consisting of methanol and chloroform (1:1, v/v), and heated at 60 °C
for 4 hours. Potassium tert-butoxide was added to basify the solution
and the mixture was centrifuged at 2500 rpm for 15 min to obtain
precipitates, which were water soluble DHLA conjugated carbon dots
(DHLA-CDs). The product was further characterized by spectroscopy
of UV-vis, FTIR, fluorescence, atomic force microscopy (AFM) and
transmission electron microscopy (TEM).

Characterization of human insulin fibrillation
Human insulin was dissolved in hydrochloric acid aqueous
solution (pH 1.6) with 100Mm sodium chloride to a concentration
of 1 mg/mL and incubated at 37 °C with stirring in a sand bath [27].
Insulin/DHLA-CDs mixture samples were also prepared at the same
concentration of protein in the presence of 0.2 or 2 µg/mL of DHLACDs. Aliquots of samples were withdrawn at various time periods and
characterized for fibril formation with the following methods.
Thioflavin T (ThT) fluorescence was recorded on a Fluorolog-3
spectrofluorometer at an excitation wavelength of 450 nm in a quartz
J Parkinsons Dis Alzheimer Dis 1(1): 7 (2015)

cuvette with 1 cm optical path length. Aliquots of protein solutions
were diluted with ThT solution to 0.1 mg/mL of protein and 20 µM
of ThT. In all measurements of fluorescence, emission and excitation
slit widths were set at 5 nm. The experiments were repeated three
times and average emission intensity at 485 nm was plotted against
incubation time.
Circular dichroism spectra were obtained on a JASCO J-810
spectropolarimeter (Easton, MD). The spectra were recorded between
190 and 260 nm at room temperature employing a 2 mm optical path
length quartz cell. The spectra were measured using diluted aliquots
(to 0.1 mg/mL of insulin) withdrawn from the human insulin or
insulin/DHLA-CDs mixture solutions.
Atomic force microscopy images were taken with tapping
mode by an Agilent 5420 AFM instrument (Santa Clara, CA) with
a resolution of 512×512 pixels. The cantilever had a resonance
frequency of ~170 kHz with typical force constant of 7.5 N/m. The
sample was drop-coated on a freshly cleaved mica slide and allowed
to dry. Then the sample coated mica slide was gently washed with
pure water to remove the salt and allowed to air dry. Transmission
electron microscopy (TEM) image of DHLA-CDs was obtained on a
JEOL 1200X TEM.

Results and Discussion
Characterization of hydrophobic CDs and DHLA-CDs
The hydrophobic carbon dots were synthesized using the
procedure reported by Wang et al. [25]. The as-prepared hydrophobic
carbon dots are soluble in chloroform and highly fluorescent under
365 nm UV lamp (Figure 1A). The UV-vis absorption spectrum
contains a peak at about 360 nm (Figure 1B). The maximal
fluorescence emission peak of these carbon dots is dependent on
the excitation wavelength (Figures 1C and 1D), and it shifts toward
higher wavelengths when excited at larger wavelengths. The size of
the prepared hydrophobic CDs is about 6-8 nm based on atomic force
microscopy imaging. All these characterizations are consistent with
the results reported before [25].
CDs were conjugated with DHLA to increase their water
solubility. After preparation, the DHLA-CDs were characterized by
FTIR, UV-Vis, fluorescence and AFM (Figure 2). As displayed in
Figure 2A, the absorbance peaks of the carboxyl group at 1705 cm-1 in
CDs and DHLA vanished after conjugation, while a weak peak around
1017 cm-1 appeared in DHLA-CDs. These observations suggest the
formation of a thioester. Compared with CDs in chloroform, the
UV-vis absorption peak of DHLA-CDs in water becomes weaker
and blue shifted to about 325 nm (Figure 2B). In addition, the
maximal fluorescence intensity of DHLA-CDs in aqueous solution
becomes much smaller after conjugation compared to that of CDs in
chloroform at the same concentration (i.e. 0.15 mg/mL, Figure 2C).
It is worth noting that the sharp peaks in Figure 2C are caused by
the Raman scattering. The fluorescence emission peak is the broad
one neighboring the Raman scattering peaks. Compared to the
strong emission of the core (Figure 1C), the reduced fluorescence of
DHLA-CDs is likely due to the presence of DHLA outside the surface
of the hydrophobic core of CDs, modifying the surface passivation
of CDs. The atomic force microscopy (AFM) image in Figure 2D
illustrates the morphology of CDs after conjugation, which shows the
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Figure 1: (A) Hydrophobic carbon dots dissolved in chloroform under regular light or 365 nm UV lamp; (B) UV-vis absorption of hydrophobic carbon dots at 0.8
mg/mL in chloroform; (C) Fluorescence spectra of hydrophobic carbon dots at 0.15 mg/mL in chloroform under various excitation wavelengths; (D) Normalized
fluorescence spectra.

Figure 2: (A) FTIR spectra of hydrophobic carbon dots (CDs), DHLA, and DHLA conjugated CDs (DHLA-CDs); (B) UV-vis absorption of DHLA–CDs in water; (C)
Fluorescence emission spectra of 0.15 mg/mL DHLA-CDs in water (i.e. the broad peaks neighboring the Raman scattering) under various excitation wavelengths;
(D) AFM and (E) TEM image of DHLA-CDs.
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height profile ranging from 12 to 20 nm. The transmission electron
microscopy (TEM) image in Figure 2E displays that the sizes of the
particles are between 10 to 30 nm.

Thioflavin T fluorescence of human insulin incubated with
DHLA-CDs
Human insulin solutions were incubated at a constant insulin
concentration of 1 mg/mL in 100 mM NaCl solution at pH 1.6 in the
absence or presence of DHLA-CDs at 37 °C. It has been previously
reported that human insulin is able to form fibrils in vitro under
these ionic strength, pH and temperature conditions [27]. Similar to
the fibrillation of other proteins, it is proposed that human insulin
undergoes its fibrillation process through a three-state transition: (1)
a lag phase, (2) an initiation stage where fibril formation starts taking
place and increases rapidly with time and (3) the final saturation
phase which features a plateau of mature fibril formation [28,29].
Figure 3 exhibits thioflavin T (ThT) fluorescence of human insulin
in the absence and presence of DHLA-CDs (i.e. 0, 0.2 and 2 µg/mL).
The intensity of fluorescence emission of ThT at 485 nm increases
with incubation time, indicating the formation of insulin fibrils [3032]. All the samples containing human insulin show an increase
in fluorescence intensity with the time of incubation, while 2 µg/
mL DHLA-CDs alone does not display ThT fluorescence intensity
increase at 485 nm with the time of incubation. For the insulin sample
(black curve in Figure 3), a well-defined lag time is observed where
there is no significant increase in ThT fluorescence intensity at 485
nm for the first 4 hours of incubation. After the first 4 hours, a gradual
increase in intensity is observed, which reaches a plateau after about
6 hours of incubation. However, in the presence of 0.2 or 2 µg/mL
of DHLA-CDs, an increase of fluorescence intensity at 485 nm is
observed at the beginning (red and blue curves in Figure 3). The lag
phase time is significantly reduced in the presence of DHLA-CDs. At
each time period of incubation, higher concentrations of DHLA-CDs
have greater ThT fluorescence intensity, suggesting that the presence
of more DHLA-CD results in a higher rate of insulin fibrillation.

Secondary conformational changes of human insulin
incubated with DHLA-CDs
Circular dichroism is a spectroscopic technique widely used
to characterize conformational changes of proteins and peptides
[33-35]. In the experiment, the conformational changes of human
insulin in the absence and presence of DHLA-CDs were monitored
with circular dichroism spectroscopy during the fibrillation process.
Figures 4A-4C shows the spectra of aliquots withdrawn at incubation
times of 0, 3.5 and 6 hours, respectively. In the absence and presence
of DHLA-CDs, human insulin at time 0 has almost exactly the same
circular dichroism spectra with two negative bands at 208 and 222
nm, which are characteristics of the α-helix conformation (Figure
4A). After 3.5 hours of incubation, the peak at 208 nm becomes
weaker and a broad band around 218 nm begins to appear, indicating
that the secondary conformation changes from α-helix to β-sheet
(Figure 4B). It is worth noting that human insulin at time 3.5 hours
in the presence of DHLA-CDs experiences a larger conformational
change than that in the absence of DHLA-CDs based on the ellipticity
at 218 nm. After 6 hours of incubation, human insulin changes to
β-sheet in all cases (Figure 4C).
Circular dichroism spectra in Figure 4 indicate that all human
insulin samples are transformed to a β-sheet conformation
with increasing time of incubation. However, the rate of this
transformation increases in the presence of DHLA-CDs. Therefore,
the circular dichroism spectra illustrate that the rate of insulin’s
β-sheet transformation takes place in a shorter amount of time when
DHLA-CDs are present.

AFM imaging analysis
AFM images of samples were analyzed at 30 minutes time
intervals throughout the incubation process to monitor progress
of fibril formation. Figure 5 displays the AFM images of samples at
incubation time intervals of 0, 0.5, 3.5 and 6 hours. At time 0, all three
samples exhibit no fibril formation. The next sample was taken at 0.5
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Figure 3: Normalized thioflavin T (ThT) fluorescence intensity at 485 nm of 10-fold diluted samples against incubation time in the absence and presence of DHLACDs. The original samples contained 1 mg/mL of human insulin with 0 (black), 0.2 (red) or 2 (blue) µg/mL of DHLA-CDs. The green curve is a control experiment
with 2 µg/mL of DHLA-CDs mixed with ThT. The excitation wavelength was 450 nm.
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Figure 4: Circular dichroism spectra of human insulin incubated in the absence and presence of DHLA-CDs for (A) 0, (B) 3.5 and (C) 6 hours. The original samples
contained 1 mg/mL of human insulin with 0 (black), 0.2 (red) or 2 µg/mL (blue) of DHLA-CDs. The concentration of human insulin was diluted to 0.1 mg/mL in all
cases to obtain circular dichroism spectra. It is worth noting that the whole circular dichroism spectrum of 2 µg/mL DHLA-CDs alone is around 0 (data not shown).

Figure 5: AFM images of samples at incubation times of 0, 0.5, 3.5 and 6 hours: (A) insulin in the absence of DHLA-CDs; (B) insulin with 0.2 µg/mL of DHLA-CDs;
(C) insulin with 2 µg/mL of DHLA-CDs. The scale bar shows 1 µm.

hours after incubation at 37 °C. The topography of the human insulin
sample in the absence of DHLA-CDs looks similar to that at time 0.
This sample does not show the formation of fibrils until 3.5 hours
of incubation (Figure 5A). However, insulin fibrils are observed after
30 minutes of incubation in the presence of DHLA-CDs with height
10 ~ 20 nm and length 0.5 ~ 2 µm (Figures 5B-5C). Based on these
observations, protofibrils are expected to form during the first 30
minutes of incubation in the presence of DHLA-CDs. From AFM
images, it is difficult to judge whether the proto fibrils or fibrils bind to
or grow from the particles of DHLA-CDs. All three samples were next
measured at 6 hours and they all demonstrated the presence of fibrils.

J Parkinsons Dis Alzheimer Dis 1(1): 7 (2015)

Therefore, the AFM images also confirm that the presence of DHLACDs increases the rate of human insulin fibrillation by shortening the
lag phase time. Mature insulin fibrils are observed within 30 minutes
of incubation in the presence of DHLA-CDs, whereas it takes about
3.5 hours for insulin fibrils to appear in the absence of DHLA-CDs.

Discussion
It is widely accepted that the typical protein fibrillation process
involves a number of intermediate states, including nucleation,
oligomerization, and fibril formation [3,28,29,36]. The formation of
the nucleation species (also called lag phase) is the key rate-determining
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step, as it is a thermodynamically unfavored process during
protein fibrillation. It has been known recently that the presence of
nanoparticles can significantly affect protein conformation as a result
of the interactions between nanoparticles and proteins [12,14,15,21].
Therefore, it is not unexpected that the presence of nanoparticles
may accelerate or inhibit protein fibrillation. Although extensive
studies are now being carried out on the effects of nanoparticles on
protein fibrillation, our current knowledge still relies on a case-bycase approach [37]. In general, the effects are due to the interaction
between proteins and the surface of nanoparticles, depending on the
protein surface properties (charge, stability, hydrophobicity), and on
the nanoparticle characteristics (charge, size, coating, components)
[12,14,15,37].
In the present study, an accelerating effect on human insulin
fibrillation, by shortening the lag phase time, was observed in
the presence of DHLA-CDs. Although the detailed molecular
mechanism of nucleation on the surface of these nanoparticles
remains elusive, the fibrillation process is believed to be associated
with the locally increased concentration of insulin in the vicinity
of the nanoparticle surface due to the adsorption [12,38-40]. It is
worth noting that the adsorption is likely from weak interactions,
such as hydrophobic interaction, hydrogen bonding and electrostatic
interaction. Among them, the major contributor is expected to be the
hydrophobic interaction between human insulin and the surface of
DHLA-CDs. The surface of the core of CDs and the carbon chain
of DHLA are both hydrophobic, providing a hydrophobic interface
for the insulin adsorption. Similar to the scenario of insulin at a
hydrophilic-hydrophobic interface, the insulin monomers unfold
the native conformations followed by the adsorption [3,41-43]. This
process facilitates the subsequent assembly of disordered oligomeric
structures. Thereafter, these assemblies undergo a process of reordering into β-sheet structures, which are driven by hydrogen
bonding formation [40].
The enhanced fibrillation effect was more obvious at higher
concentrations of DHLA-CDs under the same concentration of
human insulin. Parameters of nanoparticles under this condition
were the same, such as surface charge, coating, and surface curvature.
The main difference may come from the total surface area available
on DHLA-CDs for insulin adsorption. Upon adsorption, the insulin
monomers unfold the conformations, which facilitate the formation
of insulin oligomers. At higher concentrations of DHLA-CDs, larger
surface areas are available for unfolding insulin monomers, thus
generating more oligomers. The continuing assembly of oligomers
will produce more nuclei. Once the critical concentration of
nucleation is reached, elongation of insulin fibrils will rapidly occur.
Most recently we reported that water soluble fluorescent CDs
with an average diameter of 4 nm were prepared by a “top-down”
approach from oxidizing carbon nanopowder. Our experiments
demonstrated that these CDs strongly inhibit human insulin
fibrillation in a concentration–dependent manner [21]. Increasing
the concentration of CDs enhances the inhibiting effect. On the
contrary, the presence of the DHLA-CDs in this study promotes
human insulin fibrillation in a concentration-dependent manner.
One has to point out that the DHLA-CDs have completely different
nature in terms of size, surface property and component from those
J Parkinsons Dis Alzheimer Dis 1(1): 7 (2015)

we reported in Reference [21]. As displayed in Figure 2D and 2E, the
size of the DHLA-CDs is much larger (i.e. 10~30 nm) than those water
soluble fluorescent CDs. Strictly speaking, the DHLA-CDs should not
be called carbon dots any more due to the large size. Furthermore,
the DHLA-CDs have a hydrophobic core capped by dihydrolipoic
acid which has a long nonpolar carbon chain. On the other hand,
the surface of the CDs used in Reference [21] is highly hydrophilic
with plenty of carboxylic groups. To summarize, we believe that these
differences of size, surface property and component determine the
opposite observations on human insulin fibrillation. As mentioned in
the introduction, our current knowledge of nanoparticles influencing
protein fibrillation still relies on a case-by-case approach [12,14,15].

Conclusions
Protein fibrillation has been found to play a significant role in
several human diseases, such as Alzheimer’s disease, Parkinson’s
disease and type 2 diabetes. Some nanoparticles have been shown
to have potential applications in nanomedicine and biomedical
engineering due to their interactions with proteins. Carbon dots,
as a new type of nanoparticle, have been extensively studied for
their applications in biological systems, but their effects on protein
fibrillation remain elusive. In this study, DHLA-conjugated carbon
dots were synthesized by capping the hydrophobic core with
dihydrolipoic acid. Their effect on human insulin fibrillation was
investigated in vitro by incubation at 37 °C. The experiments illustrate
that the presence of DHLA-CDs results in a higher rate of human
insulin fibrillation, accelerating the secondary conformational
change of human insulin from α-helix to β-sheet. This promoting
effect of DHLA-CDs may be associated with the locally increased
concentration of human insulin adsorbed on their surface and
conformational changes after adsorption.
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